GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Distribution » Medipal Holdings Corp (TSE:7459) » Definitions » Gross Profit

Medipal Holdings (TSE:7459) Gross Profit : 円246,654 Mil (TTM As of Dec. 2023)


View and export this data going back to 1995. Start your Free Trial

What is Medipal Holdings Gross Profit?

Medipal Holdings's gross profit for the three months ended in Dec. 2023 was 円65,295 Mil. Medipal Holdings's gross profit for the trailing twelve months (TTM) ended in Dec. 2023 was 円246,654 Mil.

Gross Margin % is calculated as gross profit divided by its revenue. Medipal Holdings's gross profit for the three months ended in Dec. 2023 was 円65,295 Mil. Medipal Holdings's Revenue for the three months ended in Dec. 2023 was 円935,926 Mil. Therefore, Medipal Holdings's Gross Margin % for the quarter that ended in Dec. 2023 was 6.98%.

Medipal Holdings had a gross margin of 6.98% for the quarter that ended in Dec. 2023 => No sustainable competitive advantage

During the past 13 years, the highest Gross Margin % of Medipal Holdings was 7.31%. The lowest was 6.61%. And the median was 7.09%.

Warning Sign:

Medipal Holdings Corp gross margin has been in long-term decline. The average rate of decline per year is -1.5%.


Medipal Holdings Gross Profit Historical Data

The historical data trend for Medipal Holdings's Gross Profit can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Medipal Holdings Gross Profit Chart

Medipal Holdings Annual Data
Trend Mar15 Mar16 Mar17 Mar18 Mar19 Mar20 Mar21 Mar22 Mar23 Mar24
Gross Profit
Get a 7-Day Free Trial Premium Member Only Premium Member Only 236,739.00 214,259.00 217,445.00 224,304.00 246,654.00

Medipal Holdings Quarterly Data
Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24
Gross Profit Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 53,603.00 59,336.00 62,039.00 65,295.00 59,984.00

Competitive Comparison of Medipal Holdings's Gross Profit

For the Medical Distribution subindustry, Medipal Holdings's Gross Profit, along with its competitors' market caps and Gross Profit data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Medipal Holdings's Gross Profit Distribution in the Medical Distribution Industry

For the Medical Distribution industry and Healthcare sector, Medipal Holdings's Gross Profit distribution charts can be found below:

* The bar in red indicates where Medipal Holdings's Gross Profit falls into.



Medipal Holdings Gross Profit Calculation

Gross Profit is the different between the sale prices and the cost of buying or producing the goods.

Medipal Holdings's Gross Profit for the fiscal year that ended in Mar. 2024 is calculated as

Gross Profit (A: Mar. 2024 )=Revenue - Cost of Goods Sold
=3558732 - 3312078
=246,654

Medipal Holdings's Gross Profit for the quarter that ended in Dec. 2023 is calculated as

Gross Profit (Q: Dec. 2023 )=Revenue - Cost of Goods Sold
=935926 - 870631
=65,295

Gross Profit for the trailing twelve months (TTM) ended in Dec. 2023 adds up the quarterly data reported by the company within the most recent 12 months, which was 円246,654 Mil.

Gross Profit is the numerator in the calculation of Gross Margin.

Medipal Holdings's Gross Margin % for the quarter that ended in Dec. 2023 is calculated as

Gross Margin % (Q: Dec. 2023 )=Gross Profit (Q: Dec. 2023 ) / Revenue (Q: Dec. 2023 )
=(Revenue - Cost of Goods Sold) / Revenue
=65,295 / 935926
=6.98 %

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

A positive Gross Profit is only the first step for a company to make a net profit. The gross profit needs to be big enough to also cover related labor, equipment, rental, marketing/advertising, research and development and a lot of other costs in selling the products.


Medipal Holdings  (TSE:7459) Gross Profit Explanation

Warren Buffett believes that firms with excellent long term economics tend to have consistently higher margins.

Durable competitive advantage creates a high Gross Margin % because of the freedom to price in excess of cost. Companies can be categorized by their Gross Margin %

1. Greater than 40% = Durable competitive advantage
2. Less than 40% = Competition eroding margins
3. Less than 20% = no sustainable competitive advantage
Consistency of Gross Margin is key

Medipal Holdings had a gross margin of 6.98% for the quarter that ended in Dec. 2023 => No sustainable competitive advantage


Medipal Holdings Gross Profit Related Terms

Thank you for viewing the detailed overview of Medipal Holdings's Gross Profit provided by GuruFocus.com. Please click on the following links to see related term pages.


Medipal Holdings (TSE:7459) Business Description

Traded in Other Exchanges
Address
2-7-15, Yaesu, Chuo-ku, Tokyo, JPN, 104-8461
Medipal Holdings Corp distributes pharmaceuticals and health and beauty products to medical institutions and retailers. The firm operates in three segments: prescription pharmaceutical wholesale; cosmetics, daily necessities, and OTC pharmaceutical wholesale; and animal health products wholesale. The prescription pharmaceutical business generates the majority of revenue and distributes products to hospitals, clinics, and pharmacies. The cosmetics, daily necessities, and OTC pharmaceutical businesses distribute products to drugstores, convenience stores, and supermarkets. The animal health segment conducts wholesale business for animal hospitals, farms, and agricultural cooperatives. Medipal Holdings generates the vast majority of its revenue in Japan.

Medipal Holdings (TSE:7459) Headlines

No Headlines